Dr. Athena Starlard-Davenport is Assistant Professor of Genetics, Genomics and Informatics at University of Tennessee Health Science Center (UTHSC) in Memphis, TN. Dr. Starlard-Davenport earned a Masters in Biology at University of Louisiana at Monroe and a PhD in Biochemistry and Molecular from the University of Arkansas for Medical Sciences, College of Medicine. Following her graduate studies, Dr. Starlard-Davenport spent several years at the Food and Drug Administration (FDA) as an ORISE post-doctoral fellow at the Center for Toxicological Research, an FDA Commissioner's Fellow, and as a staff fellow. She then returned to the University of Arkansas for Medical Sciences to design tools to promote and increase cancer awareness and the importance of biobanking as part of the Department of Cancer Control and Population Sciences. Dr. Starlard-Davenport is now at UTHSC where she leads as PI the Sistas Taking A stand for breast cancer Research (STAR) study. Dr. Starlard-Davenport is a current (2019-2021) Human Genetics Scholar with the American Society of Human Genetics (ASHG).
Recent Publications
- Bajpai, AK, Gu, Q, Jiao, Y, Starlard-Davenport, A, Gu, W, Quarles, LD, Xiao, Z, Lu, L. Systems genetics and bioinformatics analyses using ESR1-correlated genes identify potential candidates underlying female bone development. Genomics 2024; 116 (1): 110769. PubMed PMID:38141931 PubMed Central PMC10811775.
- Desalegn, Z, Smith, A, Yohannes, M, Cao, X, Anberber, E, Bekuretsion, Y, Assefa, M, Bauer, M, Vetter, M, Kantelhardt, EJ et al.. Human Breast Tissue Microbiota Reveals Unique Microbial Signatures that Correlate with Prognostic Features in Adult Ethiopian Women with Breast Cancer. Cancers (Basel) 2023; 15 (19): . PubMed PMID:37835588 PubMed Central PMC10571711.
- Gu, Q, Kumar, A, Hook, M, Xu, F, Bajpai, AK, Starlard-Davenport, A, Yue, J, Jablonski, MM, Lu, L. Exploring Early-Stage Retinal Neurodegeneration in Murine Pigmentary Glaucoma: Insights From Gene Networks and miRNA Regulation Analyses. Invest Ophthalmol Vis Sci 2023; 64 (12): 25. PubMed PMID:37707836 PubMed Central PMC10506683.
- Gu, Q, Orgil, BO, Bajpai, AK, Chen, Y, Ashbrook, DG, Starlard-Davenport, A, Towbin, JA, Lebeche, D, Purevjav, E, Sheng, H et al.. Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways. Int J Mol Sci 2023; 24 (16): . PubMed PMID:37628941 PubMed Central PMC10454158.
- Coleman, TM, Starlard-Davenport, A, Onwuemene, OA, Stepleman, LM, Pace, BS. Peer mentoring to support career advancement among underrepresented minority faculty in the programs to increase diversity among individuals engaged in health-related research (PRIDE). J Clin Transl Sci 2023; 7 (1): e107. PubMed PMID:37313375 PubMed Central PMC10260328.
- Wang, X, Bajpai, AK, Gu, Q, Ashbrook, DG, Starlard-Davenport, A, Lu, L. Weighted gene co-expression network analysis identifies key hub genes and pathways in acute myeloid leukemia. Front Genet 2023; 14 : 1009462. PubMed PMID:36923792 PubMed Central PMC10008864.
- Bajpai, AK, Gu, Q, Orgil, BO, Xu, F, Torres-Rojas, C, Zhao, W, Chen, C, Starlard-Davenport, A, Jones, B, Lebeche, D et al.. Cardiac copper content and its relationship with heart physiology: Insights based on quantitative genetic and functional analyses using BXD family mice. Front Cardiovasc Med 2023; 10 : 1089963. PubMed PMID:36818345 PubMed Central PMC9931904.
- Gu, Q, Palani, CD, Smith, A, Li, B, Amos-Abanyie, EK, Ogu, U, Lu, L, Pace, BS, Starlard-Davenport, A. MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice. Front Med (Lausanne) 2022; 9 : 1043686. PubMed PMID:36507536 PubMed Central PMC9732025.
- Smith, A, Cao, X, Gu, Q, Kubi Amos-Abanyie, E, Tolley, EA, Vidal, G, Lyn-Cook, B, Starlard-Davenport, A. Characterization of the Metabolome of Breast Tissues from Non-Hispanic Black and Non-Hispanic White Women Reveals Correlations between Microbial Dysbiosis and Enhanced Lipid Metabolism Pathways in Triple-Negative Breast Tumors. Cancers (Basel) 2022; 14 (17): . PubMed PMID:36077608 PubMed Central PMC9454857.
- Starlard-Davenport, A, Gu, Q, Pace, BS. Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option. Mol Diagn Ther 2022; 26 (5): 497-509. PubMed PMID:35553407 PubMed Central PMC9098152.